Literature DB >> 1375193

Analysis of Escherichia coli colonization factor antigen I linear B-cell epitopes, as determined by primate responses, following protein sequence verification.

F J Cassels1, C D Deal, R H Reid, D L Jarboe, J L Nauss, J M Carter, E C Boedeker.   

Abstract

Colonization factor antigen I (CFA/I)-bearing strains of enterotoxigenic Escherichia coli (ETEC) are responsible for a significant percentage of ETEC diarrheal disease worldwide whether the disease presents as infant diarrhea with high mortality or as traveler's diarrhea. CFA/I pili (fimbriae) are virulence determinants that consist of repeating protein subunits (pilin), are found in several ETEC serogroups, and promote attachment to human intestinal mucosa. While CFA/I pili are highly immunogenic, the antigenic determinants of CFA/I have not been defined. We wished to identify the linear B-cell epitopes within the CFA/I molecule as determined by primate response to the immunizing protein. To do this, we (i) resolved the discrepancies in the literature on the complete amino acid sequence of CFA/I by N-terminal and internal protein sequencing of purified and selected proteolytic fragments of CFA/I, (ii) utilized this sequence to synthesize 140 overlapping octapeptides covalently attached to polyethylene pins which represented the entire CFA/I protein, (iii) immunized three rhesus monkeys with multiple intramuscular injections of purified CFA/I subunit in Freund's adjuvant, and (iv) tested serum from each monkey for its ability to recognize the octapeptides in a capture enzyme-linked immunosorbent assay. Eight linear B-cell epitopes were identified; the region containing an epitope at amino acids 11 to 21 was strongly recognized by all three individual rhesus monkeys, while the amino acid stretches 22 to 29, 66 to 74, 93 to 101, and 124 to 136 each contained an epitope that was recognized by two of the three rhesus monkeys. The three other regions containing epitopes were recognized by one of the three individuals. The monkey antiserum to pilus subunits recognized native intact pili by immunogold labeling of CFA/I pili present on whole H10407 cells. Therefore, immunization with pilus subunits induces antibody that clearly recognizes both synthetic linear epitopes and intact pili. We are currently studying the importance of these defined epitope-containing regions as vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375193      PMCID: PMC257140          DOI: 10.1128/iai.60.6.2174-2181.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Human diarrheal disease caused by enterotoxigenic Escherichia coli.

Authors:  R B Sack
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

2.  Multiple peptide synthesis (Pepscan method) for the systematic analysis of B- and T-cell epitopes: Application to parasite proteins.

Authors:  M A Miles; G R Wallace; J L Clarke
Journal:  Parasitol Today       Date:  1989-12

3.  Structural probing of human lutropin using antibodies raised against synthetic peptides constructed by classical and multiple antigen peptide system approaches.

Authors:  F Troalen; A Razafindratsita; A Puisieux; T Voeltzel; C Bohuon; D Bellet; J M Bidart
Journal:  Mol Immunol       Date:  1990-04       Impact factor: 4.407

4.  Epitope mapping of the d flagellar antigen of Salmonella muenchen.

Authors:  T M Joys; F Schödel
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 5.  Epidemiology of travelers' diarrhea: current perspectives.

Authors:  K L MacDonald; M L Cohen
Journal:  Rev Infect Dis       Date:  1986 May-Jun

6.  Primary structure of the CFA1 fimbrial protein from human enterotoxigenic Escherichia coli strains.

Authors:  P Klemm
Journal:  Eur J Biochem       Date:  1982-05-17

7.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

Review 8.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

9.  Mapping the antigenic epitopes of human dihydrofolate reductase by systematic synthesis of peptides on solid supports.

Authors:  X H Tan; M Ratnam; S M Huang; P L Smith; J H Freisheim
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

10.  Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea.

Authors:  D G Evans; D J Evans; W S Tjoa; H L DuPont
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  5 in total

1.  Identification of a cross-reactive continuous B-cell epitope in enterotoxigenic Escherichia coli colonization factor antigen I.

Authors:  A Rudin; A M Svennerholm
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Characterization of an enterotoxigenic Escherichia coli strain from Africa expressing a putative colonization factor.

Authors:  S B Khalil; F J Cassels; H I Shaheen; L K Pannell; N El-Ghorab; K Kamal; M Mansour; S J Savarino; L F Peruski
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

3.  Monoclonal antibodies against enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) that cross-react immunologically with heterologous CFAs.

Authors:  A Rudin; M M McConnell; A M Svennerholm
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 4.  Colonization factors of diarrheagenic E. coli and their intestinal receptors.

Authors:  F J Cassels; M K Wolf
Journal:  J Ind Microbiol       Date:  1995-09

5.  Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.

Authors:  Jianmei Yu; Frederick Cassels; Tanya Scharton-Kersten; Scott A Hammond; Antoinette Hartman; Evelina Angov; Blaise Corthésy; Carl Alving; Gregory Glenn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.